- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/175 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine having the group , N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazonesThioanalogues thereof
Patent holdings for IPC class A61K 31/175
Total number of patents in this class: 304
10-year publication summary
|
14
|
14
|
23
|
36
|
26
|
25
|
20
|
23
|
8
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Remedy Pharmaceuticals, Inc. | 48 |
10 |
| HMI Medical Innovations, LLC | 16 |
7 |
| The Johns Hopkins University | 5667 |
5 |
| Emcure Pharmaceuticals Limited | 69 |
5 |
| Neoculi Pty Ltd | 18 |
5 |
| University of Maryland, Baltimore | 1018 |
5 |
| Nissan Chemical Corporation | 2010 |
5 |
| University of Florida Research Foundation, Inc. | 4018 |
4 |
| The Brigham and Women's Hospital, Inc. | 2185 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2812 |
4 |
| NutriLeads B.V. | 29 |
4 |
| Pop Test Oncology Limited Liability Company | 27 |
4 |
| The Research Foundation for The State University of New York | 1616 |
4 |
| Rutgers, The State University of New Jersey | 1892 |
4 |
| SK Biopharmaceuticals Co., Ltd. | 261 |
4 |
| Synta Pharmaceuticals Corp. | 179 |
4 |
| Novartis AG | 10847 |
3 |
| President and Fellows of Harvard College | 5975 |
3 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2154 |
3 |
| Centre hospitalier universitaire de Grenoble | 40 |
3 |
| Other owners | 214 |